Brief: Cara Therapeutics Announces Fourth Quarter Results
04/03/2024 21:04
March 4 (Reuters) - Cara Therapeutics Inc CARA.O :
* CARA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR
2023
FINANCIAL RESULTS
* CARA THERAPEUTICS INC: EXTENDED CASH RUNWAY INTO 2026 WITH
CLINICAL PRIORITIZATION STRATEGY AND REDUCTION IN FORCE
* CARA THERAPEUTICS INC: QTRLY LOSS PER SHARE $0.59
Source text for Eikon: ID:nGNX63bLTQ
Further company coverage: CARA.O
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM